Chemotherapy combinations with monoclonal antibodies in non-Hodgkin's lymphoma - Wikidata - awgldk - TriplyDB

Chemotherapy combinations with monoclonal antibodies in non-Hodgkin's lymphoma

Chemotherapy combinations with monoclonal antibodies in non-Hodgkin's lymphoma

http://www.wikidata.org/entity/Q24633714

about

Recent advances in the field of anti-cancer immunotherapy Discovery and canine preclinical assessment of a nontoxic procaspase-3-activating compound ATM mutations uniformly lead to ATM dysfunction in chronic lymphocytic leukemia: application of functional test using doxorubicin.Improved tumor immunity using anti-tyrosinase related protein-1 monoclonal antibody combined with DNA vaccines in murine melanoma Bendamustine for indolent non-Hodgkin lymphoma in the front-line or relapsed setting: a review of pharmacokinetics and clinical trial outcomes.Bendamustine-based therapy as first-line treatment for non-Hodgkin lymphoma.Chemotherapy-Induced Ischemic Colitis in a Patient with Jejunal Lymphoma Addition of rituximab to a CEOP regimen improved the outcome in the treatment of non-germinal center immunophenotype diffuse large B cell lymphoma cells with high Bcl-2 expression.Guanylyl cyclase C as a biomarker for targeted imaging and therapy of metastatic colorectal cancer

P2860

Q26775602-AFC0393E-34C3-4737-9DB1-D14A8F0DA33F Q28292596-60874A40-1EFA-4B35-A2C2-737CA3360EBC Q36967158-29C619B6-BBD3-4843-8DF3-F067A679D213 Q37342888-A8BE0591-58FC-479C-AEE7-41647387AF45 Q38152510-C98016A6-BBF0-4ED2-9617-6ED65DCAE6CC Q38206120-D69BCE90-291A-4D7F-8C3D-E23859D90705 Q41700408-D871C235-24B4-49C2-A004-9C4F960811CE Q54563401-3F2BDBC1-94AC-4A4C-9F5C-BDBD981C9500 Q58924867-5179ADC4-0A0F-4C92-9D18-E0947427D2B5

P2860

Chemotherapy combinations with monoclonal antibodies in non-Hodgkin's lymphoma

http://www.wikidata.org/entity/Q24633714

description

2008 nî lūn-bûn

@nan

2008 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Chemotherapy combinations with monoclonal antibodies in non-Hodgkin's lymphoma

@ast

Chemotherapy combinations with monoclonal antibodies in non-Hodgkin's lymphoma

@en

Chemotherapy combinations with monoclonal antibodies in non-Hodgkin's lymphoma

@nl

type

label

Chemotherapy combinations with monoclonal antibodies in non-Hodgkin's lymphoma

@ast

Chemotherapy combinations with monoclonal antibodies in non-Hodgkin's lymphoma

@en

Chemotherapy combinations with monoclonal antibodies in non-Hodgkin's lymphoma

@nl

prefLabel

Chemotherapy combinations with monoclonal antibodies in non-Hodgkin's lymphoma

@ast

Chemotherapy combinations with monoclonal antibodies in non-Hodgkin's lymphoma

@en

Chemotherapy combinations with monoclonal antibodies in non-Hodgkin's lymphoma

@nl

P1433

Q24633714-975AFEE8-55AE-4787-9341-F78471CE0FA7

P1476

Q24633714-EB2970EC-505A-484E-A4F7-94101A697DA5

P2093

Q24633714-15F2ED14-BB42-4A31-8953-16BB91A179F4

P2860

Q24633714-12EF0F3F-7C73-465E-99D4-173D928B6D18

Q24633714-167AD32B-4734-4BD2-AEA8-712DF904BA59

Q24633714-1963AA7A-A679-43AB-9842-757222180225

Q24633714-4D3E266E-675C-4F85-B385-BDAB590E07BC

Q24633714-661DB23D-2341-47D7-8E50-620032A076FC

Q24633714-6E1A8851-AA98-4962-AA71-28602BDFF690

Q24633714-766DD7F4-6518-440D-9F01-8AE2921C20A3

Q24633714-7CA700CD-F36F-48A2-BB7C-557085DE6B6A

Q24633714-91A8F94E-394E-495D-87A2-C977FF39F435

Q24633714-97D1FE3D-DD0A-4235-8010-A1531656CC9F

P304

Q24633714-29F897D1-FB3D-47A8-B08A-9B7171D66970

P31

Q24633714-60DAF84B-12C0-4C80-BD22-7C74BE7160B5

P356

Q24633714-4F7F36C5-C466-4EF8-AE7F-06077CC052FF

P407

Q24633714-2104D3F2-15AD-4578-A3C6-1CCC1693E643

P433

Q24633714-7369EE71-4DF0-4FC4-B8F6-452BB326E725

P478

Q24633714-E605A32F-E4F9-405A-A81C-CF618D3E4273

P577

Q24633714-4DD79AE4-D9F8-455C-984A-2405C344034E

P5875

Q24633714-6943F199-88FB-4559-A4A5-26CFE39341C5

P698

Q24633714-38E636B7-0501-4739-A538-4C87E7B34CF9

P921

Q24633714-7E0A09FD-EE2D-4D6D-BB11-1B6F20E33BB7

Q24633714-E8B7DBD0-2204-466F-8F43-79659FC797EE

P932

Q24633714-7CDFD453-DB65-4CEE-95B9-1805202F4B69

P356

J.SEMINHEMATOL.2008.02.003

P1433

Seminars in Hematology

P1476

Chemotherapy combinations with monoclonal antibodies in non-Hodgkin's lymphoma

@en

P2093

Brad Kahl

http://www.w3.org/2001/XMLSchema#string

P2860

Ongoing immunoglobulin somatic mutation in germinal center B cell-like but not in activated B cell-like diffuse large cell lymphomas

Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte

Preclinical safety evaluation of rhuMAbVEGF, an antiangiogenic humanized monoclonal antibody.

CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group.

Epratuzumab, a CD22-targeting recombinant humanized antibody with a different mode of action from rituximab.

Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma.

A pilot study of epratuzumab and rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated, diffuse large B-cell lymphoma.

Prognostic significance of microvessel density and vascular endothelial growth factor (VEGF) expression in non-Hodgkin's lymphoma.

Epratuzumab, a humanized monoclonal antibody targeting CD22: characterization of in vitro properties.

Inhibition of interleukin 10 by rituximab results in down-regulation of bcl-2 and sensitization of B-cell non-Hodgkin's lymphoma to apoptosis.

P304

90-4

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1053/J.SEMINHEMATOL.2008.02.003

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

45

http://www.w3.org/2001/XMLSchema#string

P577

2008-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5471777

http://www.w3.org/2001/XMLSchema#string

P698

18381103

http://www.w3.org/2001/XMLSchema#string

P921

P932

2919066

http://www.w3.org/2001/XMLSchema#string